$28.18
1.244.6%
Last update: Oct 7, 4:01 PM
$28.18
1.244.6%
Zenas BioPharma Inc
ZBIONASDAQ
Zenas BioPharma (ZBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.78 | $-1.54 | — | $-0.98 |
| Actual | $-1.77 | $-1.46 | $-4.54 | $-1.22 |
| Surprise | -126.9% | +5.19% | — | -24.5% |
| Revenue | ||||
| Estimate | $27.0M | — | — | $2.8M |
| Actual | $1.0M | $0 | $0 | $0 |
| Surprise | -96.3% | — | — | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.26 | $-1.28 | $-1.33 | $-0.21 |
| Revenue | ||||
| Consensus | — | $14.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-1.77 | $-0.78 | -126.9 % |
| Q1 | May 13, 2026 | $-1.46 | $-1.54 | 5.19 % |
| Q3 | Nov 12, 2025 | $-1.22 | $-0.98 | -24.5 % |
| Q2 | Aug 12, 2025 | $-1.25 | $-1.04 | -20.2 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $1.00M | $27.00M | -96.3 % |
| Q3 | Nov 12, 2025 | $0 | $2.75M | -100.0 % |
| Q2 | Aug 12, 2025 | $0 | $2.75M | -100.0 % |
| Q1 | May 15, 2025 | $10.00M | $1.67M | 498.8 % |
